Latest Diabetes News
Rate of awakenings significantly lower during hypoglycemic versus normoglycemic night.
The researchers found that factors associated with a higher risk of recurrent infections included type 2 diabetes mellitus, hypertension, and black ethnicity.
Tresiba and Ryzodeg approved for use in adults with type 1 and 2 diabetes mellitus.
Ingestion of hypertension medications at bedtime linked to reduced risk of new-onset diabetes.
Greater weight loss and improved glycemic control compared with lifestyle changes alone.
Pesticide exposure associated with a 61% increased risk for diabetes.
In type 2 diabetes, improving glycemic control may decrease dementia risk.
Combination of dextromethorphan 60 mg and sitagliptin 100 mg showed strongest effect in OGTT.
Higher numbers of insured leading to more treatment of hypertension, high cholesterol, diabetes.
Empagliflozin-treated patients had a 38% reduction in the relative risk of cardiovascular death versus placebo recipients.
Prevention of cardiovascular events in women with diabetes should be approached differently from men with the disease.
Intermittent high-intensity exercise might also improve diabetes control, researchers say.
Rates of heart attack, heart failure, and stroke cut significantly by more aggressive treatment.
And many don't know they're at risk, researchers say.
Diabetes patients treated with the drug less likely to develop oropharyngeal, nasopharyngeal cancers.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Nivolumab, Cabozantinib Improve Outcomes in Advanced Kidney Cancer
- Prostate Cancer Surgery, Radiotherapy Offer Similar Overall Survival
- Medical Nutrition Therapy Slows Time to Dialysis
- New Model More Accurately Predicts mRCC Patient Survival
- Mutation Predicts Worse Prostate Cancer Chemotherapy Outcomes